| TBXA2R |
TBXA2R: Thromboxane A2 receptor |
XCL1 |
XCL1, LTN, SCYC1: Lymphotactin precursor |
0.848 |
Evidence |
|
| TBXA2R |
TBXA2R: Thromboxane A2 receptor |
CXCL5 |
CXCL5, ENA78, SCYB5: Small-inducible cytokine B5 precursor |
0.848 |
Evidence |
|
| TBXA2R |
TBXA2R: Thromboxane A2 receptor |
PTGDS |
PTGDS, PDS: Prostaglandin-H2 D-isomerase precursor |
0.848 |
Evidence |
|
| TBXA2R |
TBXA2R: Thromboxane A2 receptor |
CCL1 |
CCL1, SCYA1: Small-inducible cytokine A1 precursor |
0.848 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
0.848 |
Evidence |
|
| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
0.848 |
Evidence |
|
| DRD1 |
DRD1: D(1A) dopamine receptor |
CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
0.848 |
Evidence |
|
| DRD1 |
DRD1: D(1A) dopamine receptor |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
0.848 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
SLA2 |
SLA2, C20orf156, SLAP2: Src-like-adapter 2 |
0.848 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
LNK |
SH2B3, LNK: SH2B adapter protein 3 |
0.848 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
ABL2 |
ABL2, ABLL, ARG: Tyrosine-protein kinase ABL2 |
0.848 |
Evidence |
|
| EPHA1 |
EPHA1, EPH, EPHT, EPHT1: Ephrin type-A receptor 1 precursor |
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
0.848 |
Evidence |
|
| KITLG |
KITLG, MGF, SCF: Kit ligand precursor |
CSF2RB |
CSF2RB, IL3RB, IL5RB: Cytokine receptor common beta chain precursor |
0.848 |
Evidence |
|
| KITLG |
KITLG, MGF, SCF: Kit ligand precursor |
IL12RB2 |
IL12RB2: Interleukin-12 receptor beta-2 chain precursor |
0.848 |
Evidence |
|
| KITLG |
KITLG, MGF, SCF: Kit ligand precursor |
IL9R |
IL9R: Interleukin-9 receptor precursor |
0.848 |
Evidence |
|
| KITLG |
KITLG, MGF, SCF: Kit ligand precursor |
LEPR |
LEPR, DB, OBR: Leptin receptor precursor |
0.848 |
Evidence |
|
| KITLG |
KITLG, MGF, SCF: Kit ligand precursor |
LIFR |
LIFR: Leukemia inhibitory factor receptor precursor |
0.848 |
Evidence |
|
| KITLG |
KITLG, MGF, SCF: Kit ligand precursor |
MPL |
MPL, TPOR: Thrombopoietin receptor precursor |
0.848 |
Evidence |
|
| KITLG |
KITLG, MGF, SCF: Kit ligand precursor |
IL6ST |
IL6ST: Interleukin-6 receptor subunit beta precursor |
0.848 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
0.848 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
0.848 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
0.848 |
Evidence |
|
| EDG1 |
EDG1: Sphingosine 1-phosphate receptor Edg-1 |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
0.848 |
Evidence |
|
| TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
CCL26 |
CCL26, SCYA26, UNQ216/PRO242: Small-inducible cytokine A26 precursor |
0.848 |
Evidence |
|
| TACR2 |
TACR2, NK2R, NKNAR, TAC2R: Substance-K receptor |
CCL15 |
CCL15, MIP5, NCC3, SCYA15: Small-inducible cytokine A15 precursor |
0.848 |
Evidence |
|